CAQ Corner

You have full text access to this OnlineOpen article

Immunosuppression in liver transplantation

  1. David J. Post1,†,*,
  2. David D. Douglas1,
  3. David C. Mulligan2

Article first published online: 19 OCT 2005

DOI: 10.1002/lt.20614

Issue

Liver Transplantation

Liver Transplantation

Volume 11, Issue 11, pages 1307–1314, November 2005

Additional Information

How to Cite

Post, D. J., Douglas, D. D. and Mulligan, D. C. (2005), Immunosuppression in liver transplantation. Liver Transpl, 11: 1307–1314. doi: 10.1002/lt.20614

Author Information

  1. 1

    Division of Transplantation Medicine, Mayo Clinic Hospital, Phoenix, AZ

  2. 2

    Division of Transplantation Surgery, Mayo Clinic Hospital, Phoenix, AZ

  1. †

    Telephone: 480-342-0805; FAX: 480-342-2324

*Department of Transplantation Medicine, Mayo Clinic, 5777 E. Mayo Blvd., Phoenix, AZ 85054

Publication History

  1. Issue published online: 19 OCT 2005
  2. Article first published online: 19 OCT 2005
  3. Manuscript Accepted: 29 AUG 2005
  4. Manuscript Received: 1 AUG 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (183K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Ciesek, H. Wedemeyer, Immunosuppression, liver injury and post-transplant HCV recurrence, Journal of Viral Hepatitis, 2012, 19, 1
    Direct Link:
  2. 2
    David W. Keckich, Janis E. Blair, Holenarasipur R. Vikram, Maria Teresa Seville, Shimon Kusne, Reactivation of Coccidioidomycosis Despite Antifungal Prophylaxis in Solid Organ Transplant Recipients, Transplantation, 2011, 92, 1, 88

    CrossRef

  3. 3
    William Gelson, Matthew Hoare, M.F. Dawwas, Sarah Vowler, Paul Gibbs, Graeme Alexander, The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom, Transplantation, 2011, 91, 11, 1240

    CrossRef

  4. 4
    William Gelson, Matthew Hoare, Esther Unitt, Christopher Palmer, Paul Gibbs, Nicholas Coleman, Susan Davies, Graeme J.M. Alexander, Heterogeneous Inflammatory Changes in Liver Graft Recipients With Normal Biochemistry, Transplantation, 2010, 89, 6, 739

    CrossRef

  5. 5
    N. Kemmer, G. Neff, Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation, Transplantation Proceedings, 2010, 42, 5, 1731

    CrossRef

  6. 6
    Bijan Eghtesad, Charles M. Miller, John J. Fung, Current Clinical Medicine, 2010,

    CrossRef

  7. 7
    Eric R. Kallwitz, Scott J. Cotler, Care of the Liver Transplant Patient, Disease-a-Month, 2008, 54, 7, 486

    CrossRef

  8. 8
    S. Olivier, K. Mohammedi, R. Roussel, Diabète chez les transplantés d’organe, Médecine des Maladies Métaboliques, 2008, 2, 6, 579

    CrossRef

  9. 9
    Daniel D. Hampton, Martin H. Poleski, Jane E. Onken, Inflammatory bowel disease following solid organ transplantation, Clinical Immunology, 2008, 128, 3, 287

    CrossRef

  10. 10
    Nina Singh, Hsin-Yun Sun, Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens, Liver Transplantation, 2008, 14, 9
    Direct Link:
  11. 11
    Hugo R. Rosen, Transplantation Immunology: What the Clinician Needs to Know for Immunotherapy, Gastroenterology, 2008, 134, 6, 1789

    CrossRef

  12. 12
    Carmen M. Stanca, M Isabel Fiel, Nickolas Kontorinis, Kaushik Agarwal, Sukru Emre, Thomas D. Schiano, Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin, Transplantation, 2007, 84, 2, 180

    CrossRef

  13. 13
    Mical S Campbell, Jitha Rai, Elliott Kozin, Roy D Bloom, James F Markmann, Kim M Olthoff, Abraham Shaked, K Rajender Reddy, Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation, Clinical Transplantation, 2007, 21, 3
    Direct Link:
  14. 14
    Antifungal Agents and Therapy,
    Direct Link:
View Full Article (HTML) Get PDF (183K)